A novel mechanism of soluble HLA-G mediated immune modulation: downregulation of T cell chemokine receptor expression and impairment of chemotaxis.
about
Mesenchymal Stem Cells and Myeloid Derived Suppressor Cells: Common Traits in Immune RegulationThe dual role of HLA-G in cancerLymphocyte cell-cycle inhibition by HLA-G is mediated by phosphatase SHP-2 and acts on the mTOR pathwayDownregulation of key early events in the mobilization of antigen-bearing dendritic cells by leukocyte immunoglobulin-like Receptor B4 in a mouse model of allergic pulmonary inflammation.Soluble human leukocyte antigen-g5 activates extracellular signal-regulated protein kinase signaling and stimulates trophoblast invasionHLA-G expression in cancers: roles in immune evasion, metastasis and target for therapyHLA-G: a look back, a look forward.Human leucocyte antigen-G: expression and function in airway allergic disease.The immunosuppressive molecule HLA-G and its clinical implications.New insights into HLA-G mediated tolerance.Soluble monomers, dimers and HLA-G-expressing extracellular vesicles: the three dimensions of structural complexity to use HLA-G as a clinical biomarker.Highlights of the third International Conference on Immunotherapy in Pediatric Oncology.Recognition of the Major Histocompatibility Complex (MHC) Class Ib Molecule H2-Q10 by the Natural Killer Cell Receptor Ly49C.Herpes B virus, macacine herpesvirus 1, breaks simplex virus tradition via major histocompatibility complex class I expression in cells from human and macaque hostsSoluble HLA-G modulates miRNA-210 and miRNA-451 expression in activated CD4+ T lymphocytes.Human leukocyte antigen-G expression and polymorphisms promote cancer development and guide cancer diagnosis/treatment.Heterogeneity of HLA-G Expression in Cancers: Facing the ChallengesThe Role of CXC Chemokine Receptors 1-4 on Immune Cells in the Tumor Microenvironment
P2860
Q26741252-BC6D769B-2BF6-4751-B2A1-1111613D626BQ26860886-5253E8B5-28CF-4317-8307-0FF155DACC83Q28476661-08D83E18-9D2F-4901-A894-828C4E30793DQ34595212-D769FC4A-FD56-4265-B8AD-0D5A5479FF35Q35009225-F18CA6EA-07A5-4761-9CF3-59675D94AC51Q36568297-27311276-64A0-405B-B3C0-6BDEA3051A5AQ37810814-7A517A24-BB97-4376-BDAF-F74E595A1FE8Q37957244-954056AB-EB7E-49E6-9FEA-647290E0F9B1Q38005743-DBA8C063-5E16-491F-9F60-013BE34AF89CQ38240763-78EF9A9B-B76E-4CD3-86EA-607FDD3EEA2FQ38839474-CB9A4F95-99E1-4FF6-86F6-B871EB4D0A3EQ39403785-0DE6EC2A-CAB2-4386-ADAA-83FE3170F6D2Q39626004-D9903CFB-FD0E-4239-83F9-5AD3C0011789Q41167115-DB880307-8D08-4752-A5F6-E7CD357F8D55Q41510335-73BF8130-5181-4316-B426-FD94FD11A85BQ49335253-41CCBF72-8F32-47F8-A9AE-A7881A5DD1C9Q57490851-475A1604-771B-4344-B7F6-8B182E8DABD0Q57492022-5A768A0B-D1DA-44A4-96F1-4D936FD251BF
P2860
A novel mechanism of soluble HLA-G mediated immune modulation: downregulation of T cell chemokine receptor expression and impairment of chemotaxis.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
A novel mechanism of soluble H ...... and impairment of chemotaxis.
@ast
A novel mechanism of soluble H ...... and impairment of chemotaxis.
@en
type
label
A novel mechanism of soluble H ...... and impairment of chemotaxis.
@ast
A novel mechanism of soluble H ...... and impairment of chemotaxis.
@en
prefLabel
A novel mechanism of soluble H ...... and impairment of chemotaxis.
@ast
A novel mechanism of soluble H ...... and impairment of chemotaxis.
@en
P2093
P2860
P50
P1433
P1476
A novel mechanism of soluble H ...... and impairment of chemotaxis.
@en
P2093
Elisa Ferretti
Ignazia Prigione
Paola Bocca
Vito Pistoia
P2860
P304
P356
10.1371/JOURNAL.PONE.0011763
P407
P577
2010-07-23T00:00:00Z